|
Volumn 483, Issue 2, 2009, Pages 165-168
|
Cancer prevention by carotenoids
|
Author keywords
Cancer prevention; Carotenoids; Clinical trial; Combinational use; Liver cancer
|
Indexed keywords
ALPHA CAROTENE;
BETA CAROTENE;
BETA CRYPTOXANTHIN;
CAROTENOID;
FUCOXANTHIN;
INOSITOL;
LYCOPENE;
PHYTOENE;
PHYTOFLUENE;
UNCLASSIFIED DRUG;
XANTHOPHYLL;
ZEAXANTHIN;
ANTINEOPLASTIC ACTIVITY;
BLADDER CANCER;
CANCER INCIDENCE;
CANCER PREVENTION;
COLON CARCINOGENESIS;
DRUG CAPSULE;
DRUG POTENCY;
DUODENUM CANCER;
ESOPHAGUS CANCER;
HUMAN;
LIVER CANCER;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LUNG CANCER;
LUNG CARCINOGENESIS;
MANDARIN;
NONHUMAN;
ORANGE JUICE;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
SKIN CARCINOGENESIS;
TREATMENT RESPONSE;
UTERINE CERVIX CANCER;
VIRUS HEPATITIS;
ANIMALS;
CAROTENOIDS;
INCIDENCE;
LIVER NEOPLASMS, EXPERIMENTAL;
MALE;
MICE;
RATS;
CITRUS RETICULATA;
|
EID: 62349134485
PISSN: 00039861
EISSN: 10960384
Source Type: Journal
DOI: 10.1016/j.abb.2008.09.011 Document Type: Review |
Times cited : (213)
|
References (10)
|